Ashlyn Pinto

690 total citations · 1 hit paper
10 papers, 430 citations indexed

About

Ashlyn Pinto is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Economics and Econometrics. According to data from OpenAlex, Ashlyn Pinto has authored 10 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Ophthalmology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Economics and Econometrics. Recurrent topics in Ashlyn Pinto's work include Retinal and Optic Conditions (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Economic and Financial Impacts of Cancer (2 papers). Ashlyn Pinto is often cited by papers focused on Retinal and Optic Conditions (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Economic and Financial Impacts of Cancer (2 papers). Ashlyn Pinto collaborates with scholars based in Canada, United Kingdom and United States. Ashlyn Pinto's co-authors include Huseyin Naci, Courtney Davis, Evrim Gurpinar, Elita Poplavska, Ajay Aggarwal, Elías Mossialos, Theodore J. Witek, Natasha Y. Sheikhan, Patrick Lefèbvre and R. Rishi Gupta and has published in prestigious journals such as BMJ, American Journal of Ophthalmology and JAMA Network Open.

In The Last Decade

Ashlyn Pinto

7 papers receiving 416 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13

2017 376 citations Courtney Davis, Huseyin Naci et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashlyn Pinto Canada	5	262	95	59	47	34	10	430
Elita Poplavska Latvia	4	266 1.0×	93 1.0×	54 0.9×	46 1.0×	37 1.1×	12	435
Thomas Michaeli Germany	13	240 0.9×	55 0.6×	36 0.6×	44 0.9×	25 0.7×	39	467
Scott Gavura Canada	11	170 0.6×	252 2.7×	27 0.5×	70 1.5×	52 1.5×	43	512
Alar Irs Estonia	8	146 0.6×	89 0.9×	79 1.3×	50 1.1×	74 2.2×	16	434
Stephanie L. Van Bebber United States	11	132 0.5×	173 1.8×	35 0.6×	57 1.2×	28 0.8×	17	491
Saskia de Groot Netherlands	12	171 0.7×	114 1.2×	21 0.4×	24 0.5×	27 0.8×	35	440
G. Caleb Alexander United States	8	169 0.6×	28 0.3×	57 1.0×	18 0.4×	22 0.6×	11	391
Stephanie Van Bebber United States	7	115 0.4×	82 0.9×	23 0.4×	18 0.4×	37 1.1×	10	338
Sarah Goring United States	15	93 0.4×	154 1.6×	67 1.1×	33 0.7×	42 1.2×	37	613
Ellie Siden Canada	10	85 0.3×	81 0.9×	110 1.9×	110 2.3×	54 1.6×	15	527

Countries citing papers authored by Ashlyn Pinto

Since Specialization

Citations

This map shows the geographic impact of Ashlyn Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashlyn Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashlyn Pinto more than expected).

Fields of papers citing papers by Ashlyn Pinto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashlyn Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashlyn Pinto. The network helps show where Ashlyn Pinto may publish in the future.

Co-authorship network of co-authors of Ashlyn Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Ashlyn Pinto. A scholar is included among the top collaborators of Ashlyn Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashlyn Pinto. Ashlyn Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Pinto, Ashlyn, et al.. (2024). Serpiginous Choroiditis After COVID-19 Infection. Journal of VitreoRetinal Diseases. 9(2). 246–252.

2.

Pinto, Ashlyn, et al.. (2024). Bilateral non-arteritic posterior ischaemic optic neuropathy following COVID-19 vaccination. BMJ Case Reports. 17(2). e256860–e256860.

3.

Pinto, Ashlyn, Nieraj Jain, & R. Rishi Gupta. (2024). Pentosan Polysulfate Maculopathy With 13 Years of Follow-up Imaging. Journal of VitreoRetinal Diseases. 8(3). 325–333. 1 indexed citations

4.

Pinto, Ashlyn, et al.. (2023). Association Between Indication for Descemet Stripping Automated Endothelial Keratoplasty and Rural Residency. Cornea. 43(3). 349–355. 1 indexed citations

5.

Pinto, Ashlyn, et al.. (2023). Pars Plana Vitrectomy for Vitreomacular Traction Resulting in Persistent Postoperative Loculated Foveal Subretinal Fluid. Journal of VitreoRetinal Diseases. 7(6). 552–556.

6.

Sheikhan, Natasha Y., et al.. (2021). Drug Advertising Violations: A Longitudinal Trend Analysis of FDA Enforcement Letters from 2005 to 2019. Pharmaceutical Medicine. 35(1). 31–38. 4 indexed citations

7.

Yu, Caberry W., Lily Park, Ashlyn Pinto, et al.. (2021). The Impact of Bariatric Surgery on Diabetic Retinopathy: A Systematic Review and Meta-Analysis. American Journal of Ophthalmology. 225. 117–127. 13 indexed citations

8.

Sheikhan, Natasha Y., et al.. (2021). Compliance With Cannabis Act Regulations Regarding Online Promotion Among Canadian Commercial Cannabis-Licensed Firms. JAMA Network Open. 4(7). e2116551–e2116551. 17 indexed citations

9.

Pinto, Ashlyn, et al.. (2020). Association Between the Use of Surrogate Measures in Pivotal Trials and Health Technology Assessment Decisions: A Retrospective Analysis of NICE and CADTH Reviews of Cancer Drugs. Value in Health. 23(3). 319–327. 18 indexed citations

10.

Davis, Courtney, Huseyin Naci, Evrim Gurpinar, et al.. (2017). Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13. BMJ. 359. j4530–j4530. 376 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact